Airwheel Extends Smart Rideable Carry-On Hand Scooter Ai Wheel Robot 20inch Cabin Luxury Suitcase Momentum at the 140th Canton Fair 
MicroVision Begins Commercial Production of MOVIA(TM) Pro for Superior Short-Range Sensing and Onboard Perception, Enabling Physical AI at the Edge 
ASN 2026: HighTide Therapeutics Presents New HTD1801 Data Highlighting Therapeutic Potential in Chronic Kidney Disease 
New Global Initiative Seeks to Modernize Health Workforce Mobility 
P&G, Nestle, Mars, AstraZeneca, ITC and Bekaert win OMP Supply Chain Awards Titan Logix Corp. Appoints New CFO
Edmonton, Alberta–(Newsfile Corp. – August 10, 2023) – Titan Logix Corp., (TSXV: TLA) (“Titan” or…
Ciscom Corp. (CISC) Portfolio Company Diversifies Its Client Base
Toronto, Ontario–(Newsfile Corp. – August 10, 2023) – Ciscom Corp. (CSE: CISC) (“Ciscom” or “the…
Micromem-Chevron Meeting Update
Toronto, Ontario and New York, New York–(Newsfile Corp. – August 10, 2023) – Micromem Technologies…
Don’t Forget! Having Memory Seats in Vehicles Boosts Satisfaction, J.D. Power Finds
TROY, Mich.–(BUSINESS WIRE)–Although it is common for mass market car brands to lag when it…
BioFlyte Raises $5.4M in Series B Financing to Protect Critical Infrastructure from Airborne Biothreats
New financing will help scale manufacturing of BioFlyte’s novel biothreat surveillance solution to expand reach…
Abnormal Security Recognized as a Leader in AI, Cloud, and Cybersecurity by Industry and Customers Alike
Abnormal Debuts on the Forbes Cloud 100 and Secures Additional Recognition from Redpoint Ventures, Bloomberg,…
MoneyLion Teams Up With Bubba Wallace and 23XI Racing to Drive Back-To-School Change
MoneyLion donates to Boys & Girls Club of America while financially empowering teachers, parents and…
Forbes Selects AI Search & Discovery Innovator Algolia as One of the World’s Best Private Cloud Companies
Algolia Ranks in the Top 50 on the Prestigious 2023 Forbes Cloud 100 for the…
Operational Technology Cybersecurity in Manufacturing: Exploring the Invisible Risks
By Nick Creath, senior product manager at Rockwell Automation Threat actors’ potential to disrupt critical…
Defender Pharmaceuticals Phase 3 Motion Sickness Trial Results Selected for Presentation at 2023 Military Health System Research Symposium (MHSRS)
Subjects receiving DPI-386 (intranasal scopolamine gel) demonstrated significantly lower incidence of nausea, vomiting or the…
Defender Pharmaceuticals Phase 3 Motion Sickness Trial Results Selected for Presentation at 2023 Military Health System Research Symposium (MHSRS)
Subjects receiving DPI-386 (intranasal scopolamine gel) demonstrated significantly lower incidence of nausea, vomiting or the…
Medigene AG to report Second Quarter and Six Months 2023 Financial Results and Corporate Update on August 17, 2023
Planegg/Martinsried, August 10, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an…
Medigene AG to report Second Quarter and Six Months 2023 Financial Results and Corporate Update on August 17, 2023
Planegg/Martinsried, August 10, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an…
Auron Strengthens Board of Directors and Leadership Team with Industry Veterans, Victoria Richon, Ph.D. and Christopher Guiffre, J.D., MBA
Dr. Vicky Richon, Appointed to Board of Directors; Chris Guiffre Appointed President and Chief Operating Officer…
Auron Strengthens Board of Directors and Leadership Team with Industry Veterans, Victoria Richon, Ph.D. and Christopher Guiffre, J.D., MBA
Dr. Vicky Richon, Appointed to Board of Directors; Chris Guiffre Appointed President and Chief Operating Officer…
Breckenridge Distillery Announces New and Expanded Partnership with the Denver Broncos
As the Official Bourbon, and Now Vodka Sponsor of the Denver Broncos, Breckenridge Distillery Celebrates…
Breckenridge Distillery Announces New and Expanded Partnership with the Denver Broncos
As the Official Bourbon, and Now Vodka Sponsor of the Denver Broncos, Breckenridge Distillery Celebrates…
Clinigen divests global rights to four cancer support therapies to CNX Therapeutics
10 August 2023 Clinigen divests global rights to four cancer support therapies to CNX Therapeutics…
Clinigen divests global rights to four cancer support therapies to CNX Therapeutics
10 August 2023 Clinigen divests global rights to four cancer support therapies to CNX Therapeutics…
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
TEL AVIV, ISRAEL, Aug. 10, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc” or…